[8-K] Bath & Body Works, Inc. Reports Material Event

Rhea-AI Filing Summary

Bath & Body Works, Inc. reported that it has released its unaudited financial results for the third quarter of 2025 and provided earnings guidance for the fourth quarter of 2025. The company also updated its earnings guidance for the full year 2025, giving investors a view of how management currently expects the rest of the year to unfold.

These details are contained in a press release dated November 20, 2025, which is included as an exhibit to this report and incorporated by reference. The information is being furnished under the sections covering results of operations and Regulation FD disclosure, meaning it is intended to keep the market broadly informed but is not treated as being formally filed under certain liability provisions.

Insights

Equity research analyst

Bath & Body Works released Q3 2025 results and refreshed 2025 guidance.

Bath & Body Works, Inc. announced unaudited financial results for the third quarter of 2025 along with earnings guidance for the fourth quarter and updated expectations for full-year 2025. The information comes via a press release dated November 20, 2025 that is furnished as an exhibit.

This type of disclosure typically summarizes recent sales, profitability and key trends, and the guidance indicates how management currently views performance for Q4 2025 and the overall 2025 fiscal year. Because it is furnished under results of operations and Regulation FD disclosure items, it is meant to provide broad, simultaneous access to the same information for all market participants.

The actual investment impact depends on the specific revenue, margin and earnings figures and how the updated guidance compares with prior expectations, which are only available in the accompanying press release referenced as Exhibit 99.1.

0000701985false00007019852025-11-202025-11-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 20, 2025

						Bath & Body Works, Inc.
						(Exact Name of Registrant as Specified in Its Charter)
						Delaware
						(State or Other Jurisdiction of Incorporation)
1-8344									31-1029810
(Commission File Number)									(IRS Employer Identification No.)
Three Limited Parkway
Columbus,			OH						43230
(Address of Principal Executive Offices)									(Zip Code)

(614) 415-7000

(Registrant's Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $0.50 Par Value			BBWI			The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition

and

Item 7.01. Regulation FD Disclosure.

The following information, including Exhibit 99.1, is being furnished pursuant to Item 2.02, “Results of Operations and Financial Condition” and Item 7.01, “Regulation FD Disclosure” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

On November 20, 2025, Bath & Body Works, Inc. issued a press release setting forth its unaudited financial results for the third quarter of 2025 and its earnings guidance for the fourth quarter of 2025. In addition, the press release contains updated earnings guidance for the full-year 2025. A copy of the press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.

Item 9.01. Financial Statements and Exhibits.

Exhibit 99.1    Press Release of Bath & Body Works, Inc., dated November 20, 2025.

Exhibit 104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

									Bath & Body Works, Inc.
Date:			November 20, 2025			By:			/s/ EVA C. BORATTO
									Eva C. Boratto
									Chief Financial Officer

FAQ

What did Bath & Body Works (BBWI) announce in this 8-K?

Bath & Body Works, Inc. announced that it issued a press release with its unaudited financial results for the third quarter of 2025, along with earnings guidance for the fourth quarter of 2025 and updated earnings guidance for full-year 2025.

Where can investors find Bath & Body Works Q3 2025 earnings details?

The detailed Q3 2025 results and guidance are contained in a press release dated November 20, 2025, which is attached as Exhibit 99.1 and incorporated by reference.

How is the earnings information for BBWI being treated under SEC rules?

The Q3 2025 results and related guidance are being furnished under the sections for results of operations and Regulation FD disclosure and are expressly stated as not deemed filed for purposes of Section 18 of the Exchange Act.

Does the 8-K include full financial statements for Bath & Body Works?

The 8-K itself describes the event and lists exhibits; the detailed unaudited financial results for the third quarter of 2025 are provided in the attached Exhibit 99.1 press release.

Who signed the Bath & Body Works 8-K for the Q3 2025 results?

The report was signed on behalf of Bath & Body Works, Inc. by EVA C. BORATTO, Chief Financial Officer, dated November 20, 2025.

What exhibits are included with Bath & Body Works Q3 2025 8-K?

The report includes Exhibit 99.1, the press release with Q3 2025 results and guidance, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.